- hereditary predisposition to cancer
- increasing access to genetic testing
- using genetic information to tailor treatment choices in breast cancer
Dr Kemp is a Consultant in Oncogenetics and the Clinical Research Lead for the Cancer Genetics Unit.
Dr Kemp undertook her medical training at Kings College London and completed specialist training in Medical Oncology at University College Hospital. Her interest in Cancer Genetics was sparked through her research at the London Research Institute for Cancer Research UK under the supervision of Professor Ian Tomlinson. She was awarded a PhD for her thesis on the identification of novel predisposition genes in colorectal cancer.
Her twin interests of oncology and genetic predisposition to cancer led her to The Royal Marsden where she is a consultant in both the Cancer Genetics and the Breast Units. Here she seeks to increase patient access to testing for cancer predisposition genes and to use this knowledge to inform cancer treatment. She has led the Mainstream Cancer Genetics pilot within the Breast Unit.